Affordable Access

Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.

Authors
Publisher
Public Library of Science
Publication Date
Disciplines
  • Biology
  • Medicine

Abstract

Licciardi, PV; Toh, ZQ; Dunne, E; Wong, SS; Mulholland, EK; Tang, M; Robins-Browne, RM; Satzke, C (2012) Protecting against pneu- mococcal disease: critical interactions between probiotics and the airway microbiome. PLoS pathogens, 8 (6). e1002652. ISSN 1553- 7366 Downloaded from: http://researchonline.lshtm.ac.uk/1098187/ Usage Guidelines Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna- tively contact [email protected] Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/ Opinion Protecting against Pneumococcal Disease: Critical Interactions between Probiotics and the Airway Microbiome Paul V. Licciardi1,2*, Zheng Quan Toh1, Eileen Dunne1, Sook-San Wong1, Edward K. Mulholland1,3,4, Mimi Tang2,5,6, Roy M. Robins-Browne7,8, Catherine Satzke1,7,8 1 Pneumococcal Research, Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, Australia, 2Allergy and Immune Disorders, Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, Australia, 3 London School of Hygiene and Tropical Medicine, London, United Kingdom, 4Menzies School of Health Research, Darwin, Australia, 5Allergy and Immunology, Royal Children’s Hospital, Melbourne, Australia, 6Department of Paediatrics, The University of Melbourne, Melbourne, Australia, 7Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia, 8 Infectious Diseases and Microbiology, Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, Australia Streptococcus pneumoniae (the pneumococ- cus) is a predominant cause of pneumonia, meningitis, and bacteremia. It is a leading killer of children under 5 years of age, responsible for the deaths of up to 2 million children annually [1]. Most deaths occur in African and Asian developing countries; however, pneumococcal disease is also a significant problem in particular populations of deve

There are no comments yet on this publication. Be the first to share your thoughts.